The alternatively spliced exon 9 of the cystic fibrosis transmembrane
conductance regulator (CFTR) gene codes for the initial part of the am
ino-terminal nucleotide-binding fold of CFTR. A unique feature of the
acceptor splice site preceding this exon is a variable length polymorp
hism within the polypyrimidine tract influencing the extent of exon 9
skipping in CFTR mRNA. We investigated this repeat for its relationshi
p to CFTR mutations and intragenic markers on 200 chromosomes from Ger
man patients with cystic fibrosis (CF). Four frequent length variation
s were strongly associated with the four predominant haplotypes previo
usly defined by intragenic marker dimorphisms. One of these alleles di
splayed absolute linkage disequilibrium to the major CF mutation Delta
F508. Other frequent CFTR mutations were linked to one particular spl
ice site haplotype indicating that differential exon 9 skipping contri
butes little to the clinical heterogeneity among CF patients with an i
dentical mutation. We also identified a novel missense mutation (V456F
) and a novel nonsense mutation (Q414X) within the coding region of ex
on 9. The missense mutation V456F adjacent to Walker motif A was prese
nt in a pancreas-sufficient CF patient. In contrast, the pancreas-insu
fficient Q414X/Delta F508 compound heterozygote suffered from a severe
form of the disease, indicating that alternative splicing of exon 9 d
oes not overcome the deleterious effect of a stop codon within this ex
on.